Chicago White Sox sign John Brebbia to a 1-year deal to bolster their bullpen depth
The Chicago White Sox added to their bullpen depth Saturday, signing right-hander John Brebbia to a one-year deal, a source confirmed to the Tribune.
The move is pending a physical.
MLB Network’s Jon Morosi initially reported the signing and Ken Rosenthal of The Athletic reported the deal is for $5.5 million.
Brebbia, 33, is 15-15 with a 3.42 ERA and two saves in 295 career appearances (21 starts as an opener) during six seasons with the St. Louis Cardinals (2017-19) and San Francisco Giants (2021-23). He has 321 strikeouts and 90 walks in 299 2/3 career innings.
He went 3-5 with a 3.99 ERA in 40 outings (10 as an opener) for the Giants in 2023. Brebbia had 47 strikeouts and 14 walks in 38 1/3 innings, missing a portion of the season with a right lat strain.
Brebbia underwent Tommy John surgery in June 2020 and made 18 appearances for the Giants in 2021. He led the National League with 76 outings the next season (11 as an opener), going 6-2 with a 3.18 ERA, 54 strikeouts and 18 walks in 68 innings.
The signing comes on the heels of the Sox agreeing to terms on a one-year contract with left-handed reliever Tim Hill last month.
()
More Stories
Meta and TikTok fail to halt thousands of social media addiction lawsuits
A US appeals court has rejected a challenge by Meta and TikTok, allowing wider litigation against major platforms to proceed...
Harrods returns to £84.9m profit after Al Fayed compensation payouts
Harrods returned to a pre-tax profit of £84.9 million in the year to the end of January, according to its...
Beyoncé buys out LVMH’s stake in SirDavis whisky brand
Beyoncé has acquired full control of SirDavis, the American whisky brand she established two years ago with LVMH, after the...
87% of parents want entrepreneurial skills taught in schools
More than a third of British parents (35 per cent) would rather their child start a business than go to...
Cambridge Aerospace valued at $3.4bn after raising $300m
Defence technology company Cambridge Aerospace has raised $300 million at a valuation of $3.4 billion, two years after it was...
Rare disease investment rises after US voucher renewal, UK lags
Investment in rare disease biotechs has increased since the US Food and Drug Administration’s Rare Pediatric Disease Priority Review Voucher...
